MINNEAPOLIS, Sept. 26, 2016 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announced today that Dr. Carl Schwartz, Interim Chief Executive Officer of
MINNEAPOLIS, Feb. 17, 2017 (GLOBE NEWSWIRE) -- Skyline Medical, Inc. (NASDAQ:SKLN) today announced that it has received formal notice from The NASDAQ Stock Market LLC ("Nasdaq") indicating that the Company has evidenced full compliance with all requirements for continued listing on The Nasdaq
MINNEAPOLIS, Aug. 08, 2016 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces that a top-ranked U.S.
MINNEAPOLIS, Oct. 31, 2016 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces that newly-appointed board members Timothy A. Krochuk and J.
Phoenix, AZ , Nov. 13, 2017 (GLOBE NEWSWIRE) -- Uptick Newswire's "Stock Day" today announced that it has interviewed Gerald Vardzel , CEO of Helomics Corp. , the planned joint venture partner of Skyline Medical (SKLN). Starting off the interview Mr. Vardzel discussed the company’s new key